You have 9 free searches left this month | for more free features.

Malignant rhabdoid tumor (MRT)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)

Recruiting
  • Malignant Rhabdoid Tumor
  • Atypical Teratoid Rhabdoid Tumor
  • Los Angeles, California
  • +10 more
Aug 1, 2022

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

Not yet recruiting
  • Rhabdoid Tumor
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 11, 2023

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)

Recruiting
  • Atypical Teratoid/Rhabdoid Tumor
  • +17 more
  • Atezolizumab
  • +7 more
  • Birmingham, Alabama
  • +19 more
Feb 2, 2023

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

Malignant Rhabdoid Tumors (MRT), Neuroblastoma Trial in Worldwide (LEE011)

Terminated
  • Malignant Rhabdoid Tumors (MRT)
  • Neuroblastoma
  • San Francisco, California
  • +12 more
Nov 13, 2019

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)

Not yet recruiting
  • Liver Cancer
  • +5 more
  • CARE T cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Dec 1, 2021

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

Recruiting
  • Solid Tumor
  • Atlanta, Georgia
  • +4 more
Feb 8, 2022

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023